Effectiveness of cardiac transplantation for primary (AL) cardiac amyloidosis

被引:32
|
作者
Pelosi, F
Capehart, J
Roberts, WC
机构
[1] BAYLOR UNIV,MED CTR,DEPT CARDIOTHORAC SURG,DALLAS,TX 75246
[2] BAYLOR UNIV,MED CTR,DEPT PATHOL,DALLAS,TX 75246
来源
AMERICAN JOURNAL OF CARDIOLOGY | 1997年 / 79卷 / 04期
关键词
D O I
10.1016/S0002-9149(97)00806-0
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
A patient is described in whom severe cardiac dysfunction developed from amyloid deposited entirely in the walls and lumens of intramural coronary arteries, underwent cardiac transplantation, survived another 69 months, died suddenly, and at necropsy had amyloid again limited to the walls and lumens of the intramyocardial coronary arteries in the donor heart. The rather lengthy survival in this patient and the 118-month survival in a similar previously reported patient suggests that cardiac transplantation may be an appropriate procedure for some patients with cardiac amyloidosis.
引用
收藏
页码:532 / &
页数:5
相关论文
共 50 条
  • [41] PEA ARREST IN PATIENT WITH AL CARDIAC AMYLOIDOSIS
    Oman, Zachary
    Gu, Lucas
    Bourdillon, Max
    JOURNAL OF INVESTIGATIVE MEDICINE, 2018, 66 (04) : 788 - 788
  • [42] The Role of Bortezomib in Advanced Cardiac AL Amyloidosis
    Sayago, I.
    Krsnik, I.
    Jaramillo, N.
    Gomez-Bueno, M.
    Garcia-Pavia, P.
    Alonso-Pulpon, L.
    Segovia, J.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2015, 34 (04): : S70 - S70
  • [43] ISCHEMIC STROKE UNMASKS CARDIAC AL AMYLOIDOSIS
    Canha, Catarina
    Aranda, Juan
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2021, 77 (18) : 2239 - 2239
  • [44] Natural history and therapy of AL cardiac amyloidosis
    Martha Grogan
    Angela Dispenzieri
    Heart Failure Reviews, 2015, 20 : 155 - 162
  • [45] The role of gender and age in cardiac AL amyloidosis
    Raimondi, A.
    Salinaro, F.
    Mussinelli, R.
    Boldrini, M.
    Cappelli, F.
    Perfetto, F.
    Palladini, G.
    Merlini, G.
    Rapezzi, C.
    Perlini, S.
    EUROPEAN HEART JOURNAL, 2013, 34 : 538 - 538
  • [46] AL cardiac amyloidosis and arterial thromboembolic events
    Hausfater, P
    Costedoat-Chalumeau, N
    Amoura, Z
    Cacoub, P
    Papo, T
    Grateau, G
    Leblond, V
    Godeau, P
    Piette, JC
    SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 2005, 34 (04) : 315 - 319
  • [47] Advances in Diagnosis and Treatment of AL Cardiac Amyloidosis
    Sapru, Abharika
    Mohammadi, Mitchka
    Medvedova, Eva
    Masri, Ahmad
    CURRENT TREATMENT OPTIONS IN CARDIOVASCULAR MEDICINE, 2024, 26 (09) : 289 - 298
  • [48] A Transgenic Mouse Model of Cardiac AL Amyloidosis
    Martinez-Rivas, Gemma
    Ayala, Maria
    Bender, Sebastien
    Roussel, Murielle
    Jaccard, Arnaud
    Bridoux, Frank
    Sirac, Christophe
    BLOOD, 2021, 138
  • [49] Diagnostic score of cardiac involvement in AL amyloidosis
    Nicol, Martin
    Baudet, Mathilde
    Brun, Stephanie
    Harel, Stephanie
    Royer, Bruno
    Vignon, Marguerite
    Lairez, Olivier
    Lavergne, David
    Jaccard, Arnaud
    Attias, David
    Macron, Laurent
    Gayat, Etienne
    Cohen-Solal, Alain
    Arnulf, Bertrand
    Logeart, Damien
    EUROPEAN HEART JOURNAL-CARDIOVASCULAR IMAGING, 2020, 21 (05) : 542 - 548
  • [50] Prognostic value of cardiac dysautonomia in AL amyloidosis
    Nicol, M.
    Cescau, A.
    Baudet, M.
    Harel, S.
    Royer, B.
    Sarda, L.
    Solal, A. Cohen
    Arnulf, B.
    Logeart, D.
    EUROPEAN HEART JOURNAL, 2019, 40 : 1684 - 1684